The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Prevalence of hepatitis C (HCV) among people who inject drugs in Europe is very high – in excess of 50% across six countries in the region and an estimated 84% in Portugal. But a new report released by EU drug body for World Hepatitis Day (July 28), shows that a combination of new treatments and prevention interventions gives significant reason for optimism in curbing the HCV epidemic among drug users in the region.
A bold new framework, part of the ‘Start Free, Stay Free, AIDS Free’ initiative, was launched at AIDS 2016 with the aim of ending AIDS among children, adolescents and young women by 2020.
The 90-90-90 Fast-Track targets is a hot-topic at this week’s 21st International AIDS Conference in Durban, South Africa (AIDS 2016). Progress towards the targets, which call for 90% of people living with HIV to know their status, 90% on HIV treatment, and 90% virally suppressed, is acheivable but success is not uniform.
UNAIDS has raised the alarm on new HIV infections among adults and the need to step up prevention efforts with 1.9 million adults becoming infected with HIV globally each year since 2010.
The Australian Federation of AIDS Organisations this week declared that AIDS is no longer a public health issue in Australia. In contrast HIV remains a high concern, with no decline in the number of new HIV transmissions for the past decade.
Pilot study demonstrates that delivering antiretroviral treatment to individuals presenting to emergency departments with suspected acute HIV infection is highly feasible,
Only one in six of the 29 million people who are dependent on drugs are accessing the vital treatment and support services they need, according to new data released by United Nations Office on Drugs and Crime (UNODC).